弥漫性大B细胞淋巴瘤预后因素研究进展  

The progression of prognostic markers in diffuse large B cell lymphoma

作　　者：汪太松[1] 乔文礼[1] 邢岩[1] 赵晋华[1] Wang Taisong;Qiao Wenli;Xing Yan;Zhao Jinhua(Department of Nuclear Medicine,Shanghai General Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200080,China)

机构地区：[1]上海交通大学附属第一人民医院核医学科,200080

出　　处：《国际放射医学核医学杂志》2020年第3期182-188,共7页International Journal of Radiation Medicine and Nuclear Medicine

基　　金：上海市科学技术委员会科研计划项目(17411953200);上海市申康医院发展中心临床科技创新项目(SHDC22015032)。

摘　　要：弥漫性大B细胞淋巴瘤(DLBCL)是最常见的侵袭性非霍奇金B细胞淋巴瘤,具有高度异质性,识别高危患者尤为重要,目前已经发现多种因素影响其预后.笔者根据国内外的研究进展,从临床特征、分子生物学特征和PET/CT多方面对影响DLBCL患者预后的因素进行综述.Diffuse large B-cell lymphoma(DLBCL)is one of the most common types of progressive B-cell non-Hodgkin lymphoma and is characterized by strong heterogeneity.Its prognosis is influenced by many factors;hence,diagnosis for patients with high risk is important.This review discusses the prognostic factors affecting DLBCL patients on the basis of clinical factors,molecular biology characteristics,and PET/CT imaging according to domestic and global research progress.

关 键 词：淋巴瘤 大B细胞 弥漫性 正电子发射断层显像计算机体层摄影术 预后 

分 类 号：R733.1[医药卫生—肿瘤]